BLFS
BioLife Solutions Inc
NASDAQ: BLFS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$19.99
-4.35% today
Updated 2026-04-29
Market cap
$976.66M
P/E ratio
—
P/S ratio
10.15x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$18 – $30
Volume
0.4M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B6.5
Quality
B2.0
Profitability
F3.7
Valuation
D5/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$32.40
+62.08%
12-Month target
—
—
Intrinsic (DCF)
$20.59
Margin of safety
-8.06%
1 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $2.82M — positive
+ Revenue growth 63.90% QoQ
Risks
- Thin margins at -4.78%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $76.24M | $75.86M | $82.25M | $96.21M | $96.21M |
| Net income | $-139.81M | $-66.43M | $-20.18M | $-12.13M | $3.54M |
| EPS | — | — | — | — | $-0.25 |
| Free cash flow | $-18.87M | $-18.88M | $5.20M | $10.64M | $2.82M |
| Profit margin | -183.38% | -87.57% | -24.54% | -12.61% | -4.78% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-23 | FOSTER, KAREN A. | Sale | 2,577 | $19.17 |
| 2026-03-19 | WICHTERMAN, TROY | Sale | 3,749 | $19.12 |
| 2026-03-19 | WERNER, SEAN | Sale | 1,681 | $19.12 |
Peer comparison
Smart narrative
BioLife Solutions Inc trades at $19.99. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $96.21M. with profit margins at -4.78%. Our DCF model estimates intrinsic value at $20.59.
Frequently asked questions
What is BioLife Solutions Inc's stock price?
BioLife Solutions Inc (BLFS) trades at $19.99.
Is BioLife Solutions Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $20.59.
What is the price target of BioLife Solutions Inc (BLFS)?
The analyst target price is $32.40, representing +62.1% upside from the current price of $19.99.
What is the intrinsic value of BioLife Solutions Inc (BLFS)?
Based on our DCF model, intrinsic value is $20.59, a -8.1% margin of safety versus $19.99.
What is BioLife Solutions Inc's revenue?
TTM revenue is $96.21M.
Piotroski F-Score?
5/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio10.15x
ROE-3.37%
Beta2.00
50D MA$20.52
200D MA$23.77
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week-7.97%
1 month+4.77%
3 months-11.47%
YTD-17.33%
1 year—
3 years—
5 years—